Prescription des antibiotiques guidée par les biomarqueurs en médecine de famille : CRP ou PCT ? [Biomarker-guided antibiotics prescription for lower respiratory tract infections in primary care : CRP or PCT ?]
Fiche du document
11 mai 2022
- doi: 10.53738/REVMED.2022.18.781.948
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2022.18.781.948
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/35543687
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_0887FC8712AB1
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Biologic markers Biological markers Biomarkers Markers, BiochemicalCiter ce document
S. Vingerhoets et al., « Prescription des antibiotiques guidée par les biomarqueurs en médecine de famille : CRP ou PCT ? [Biomarker-guided antibiotics prescription for lower respiratory tract infections in primary care : CRP or PCT ?] », Serveur académique Lausannois, ID : 10.53738/REVMED.2022.18.781.948
Métriques
Partage / Export
Résumé
Lower respiratory tract infections are a frequent cause of excessive antibiotic prescription. The use of CRP and PCT has been evaluated by recent trials as a mean to assist antibiotic prescription. These studies suggest a safe reduction of antibiotic usage when prescription is guided by biomarkers. There is at the moment no evidence benefiting one of the biomarkers over the other, but a recent Swiss trial could suggest an added benefit for PCT. For now, PCT is less available, more expensive and not reimbursed. Democratization of its use, and/or clear thresholds for the use of CRP are additional ways that could participate to reduce excessive antibiotic prescription in primary care.